SlideShare ist ein Scribd-Unternehmen logo
1 von 44
Pemeriksaan Immunoglobulin A (IgA) dengan metode Radial Immunodiffusion Ferdy,dr/ Endang Retnowati, dr, MS, SpPK(K) TUTOR IMUNOLOGI 1
2 subklas:  IgA1 dan IgA2 Antibodi penting pada imunitas mukosa. IgA 3-5 gram/hari disekresi ke lumen intestinal 75% Ig total dihasilkan tubuh 2 Pendahuluan
Struktur Ig A Gambar 1: Struktur Ig A (Sumber: Siemel, 2006) 3
Pendahuluan 4
Arti klinis Ig A menurun: Selective IgA deficiency Infeksi Neisseria gonorrhœae 5
IgA meningkat Ig A nephropathy Penyakit kronis seperti hepatitis Sirosis hepatis Myeloma Penyakit autoimun seperti SLE 6
Pemeriksaan Immunoglobulin A Metode : Radial immunodifusion Radioimmunoassay Nefelometri ELISA 7
Presipitasi 8
9
Kurva Presipitasi Gambar2. KurvaPresipitasi. (Sheehan, 1990) 10
Gambar3. Kompleks Ag – Ab.  (Sheehan, 1990) 11
RADIAL IMMUNODIFFUSION (RID) 12 Antisera/ Ab Gel agarosa fase cair (50oC) 50 – 80 jam   cincin presipitasi Serum standar 1 Tes serum 2 8 Antisera  dalam agar Tes serum 3 dinginkan pd suhu kamar 7 Tes serum 4 Ukur diameter cincin presipitasi, tempatkan pd kurva standar  menentukan kadar imunoglobulin secara kuantitatif 6 5 Tes serum Tes serum (Handojo, 2003)
KECEPATAN DIFUSI Ukuran molekul Interaksi  matriks gel & reaktan FAKTOR Viskositas & Hidrasi gel Berat  molekul  Ag Temperatur 13 (Sheehan, 1990)
CARA PEMBACAAN RID  METODE Mancini, endpoint diffusion. Fahey, kinetic diffusion. 14 (Sheehan, 1990)
CARA PEMBACAAN RID Fahey Mancini ,[object Object]
Grafiksemilogaritmik; sumbuy:kadarygdianalisa;
sumbu x :diameter cincinpresipitasi (termasuksumuran)
Ag dibiarkanberdifusimencapaipresipitasimaks
IgA; inkubasi 48 jam
Grafik; sumbu y:kadar Ag & sumbux: cincinpresipitasi. 15 (Sheehan, 1990)
Gambar 4. Grafik Fahey (kinetic diffusion method) 16 (Sheehan, 1990)
Gambar 5. Grafik Mancini (endpoint method)  17 (Sheehan, 1990)
18 HASIL Hasil dikali  faktor  pengenceran Hasil kurang  dari standar (Sheehan, 1990)
mengisi sumuran terlalu sedikit/ banyak  menumpahkan serum pasien ke dalam gel agarosa   hasiltdkakurat perludiulang melubangi  samping  sumuran  Waktu&suhu  Inkubasi tdk tepat  KESALAHAN PEMBACAAN RID (Sheehan, 1990) 19
Gambar6. PolacincinpresipitasipadaRID(Sheehan, 1990) 20
Pemeriksaan IgA di Instalasi Patologi Klinik RSUD.dr.Soetomo Prinsip pemeriksaan (RID): Ig A serum/plasma manusia membentuk kompleks imun dengan antibodi spesifik pada gel agarose pada cakram Partigen Diameter cincin presipitasi berbanding lurus dengan konsentrasi Ig A dalam sampel Hasil dikonversi ke dalam konsentrasi Ig A menggunakan tabel nilai referensi. 21
Reagen:  Tiap plate NOR partigen mempunyai 12 sumuran imunodifusi untuk menentukan Ig A serum/plasma. Komposisi: Cakram NOR partigen mengandung lapisan agarose gel yang mengandung antiserum monospesifik terhadap Ig A dalam plasma.  Antisera diperoleh dari kelinci, domba, kuda, kambing yang diimunisasi dari manusia. Cakram NOR Partigen juga mengandung sodium azide (<1 g/l) dan sodium timerfonate (<0.1 g/l) sebagai pengawet. 22
23 Gambar7. NOR Partigen Plate (Lab. PK, 2011)
Penyimpanan dan stabilitas NOR Patigen sebaiknya disimpan pada suhu 2-8°C pada pembungkus yang belum dibuka, stabil sesuai masa berlaku Kontrol Sebaiknya digunakan kontrol sampel yang tersedia komersial 24
Spesimen serum maupun plasma segar (24 jam sesudah pengambilan) bila sampel tidak langsung dikerjakan sebaiknya disimpan pada suhu 2-8°C maksimum 8 hari  Penyimpanan pada suhu -20°C dapat bertahan hingga 1 tahun. 25
Prosedur 5 µl sampel 1 Tes serum 2 8 Antisera  dalam agar Tes serum 3 7 UKUR DIAMETER CINCIN PRESIPITASI SETELAH 48 JAM Tes serum 4 6 5 Tes serum Tes serum (Handojo, 2003)  26
Gambar8. Meβ Projector, Lab. PK. Dr. Soetomo, 2011 27
28 Gambar9. TabelReferensi (Lab. PK, 2010)
Nilai normal IgA	: 70 – 350 mg/ dL 29
TERIMAKASIH 30
we defined IgA deficiency as plasma samples with less than 100 ngIgA per mL, decreased level of IgA as plasma samples with 100 ng to600 mg IgA per mL,  and normal level of IgA as plasmasamples with more than 0.6 mg per mL as determined by the IgA-ELISA 31
IgA measurement by nephelometry Beckman Coulter, Inc. (Fullerton,Calif.). IgA levels were considered deficient when they were less than thelower limit of established age-dependent reference intervals.  These limits: 70 mg/dl for teenagers and adults,  23 mg/dl for children 3 to 12 years old,  17mg/dl for children ,3 years old. 32
Grafik Semilogaritmik 33
34 NEFELOMETRI  Nephelometri :  carapengukurankadarzatdenganmengukurpendarancahaya (scattered) yang mengenaipartikeldalamlarutan. Dasarpemeriksaan : reaksipresipitasi antigen-antibodi. Metodeinidigunakanuntukmengetahuikuantitas protein spesifiksecaralebihakuratdanprecise.
35 PRINSIP NEPHELOMETRI (1) Prinsip nephelometri : 		1. pendaran cahaya, 		2. kinetik cairan pada fase presipitasi.
36 PRINSIP NEPHELOMETRI (2) PENDARAN CAHAYA Pendarancahayadipengaruhi :  		a. diameter partikel, 	   b. panjanggelombang. Contoh : a. partikelkecil (albumin, Ig.G,Ig.M) : 		- pendarancahaya Rayleigh semetrisantaraforwarddanbackward. 		- pendarancahaya minimum dilihatpada90º darisumbercahaya.
37 PRINSIP NEPHELOMETRI (3) 	b. partikellebihbesar (komplek Ag-Ab) : 		- menghasilkanpendarancahayaRaeyleigh-Debye 		- pendarandilihatdariforward (sudutmendekatinol)      intensitascahayalebihbesar. Sudutuntukmendeteksipendarancahayaikutmenentukansensitivitas, dimanaintensitassumbercahayamakinkuatmakasudut yang dihasilkanmakinkecil
38 PRINSIP NEPHELOMETRI (4)
39 PRINSIP NEPHELOMETRI (5)

Weitere ähnliche Inhalte

Was ist angesagt?

Lecture 3- agglutination test for
Lecture 3- agglutination test forLecture 3- agglutination test for
Lecture 3- agglutination test forsaid warsame
 
44-150724PST_Peptalk_2013_AlphaLISA_immunoassays
44-150724PST_Peptalk_2013_AlphaLISA_immunoassays44-150724PST_Peptalk_2013_AlphaLISA_immunoassays
44-150724PST_Peptalk_2013_AlphaLISA_immunoassaysMichael A. Lomotan
 
Explaining Biocide Tolerance of Gram Negative Bacteria
Explaining Biocide Tolerance of Gram Negative Bacteria Explaining Biocide Tolerance of Gram Negative Bacteria
Explaining Biocide Tolerance of Gram Negative Bacteria Kate Barlow
 
Radioimmunoassay and related immunoassay techniques
Radioimmunoassay and related immunoassay techniquesRadioimmunoassay and related immunoassay techniques
Radioimmunoassay and related immunoassay techniquesJayeshRajput7
 
Peritoneal Dialysis And Secondary Renal Function
Peritoneal Dialysis And Secondary Renal FunctionPeritoneal Dialysis And Secondary Renal Function
Peritoneal Dialysis And Secondary Renal FunctionRodion Stolyar
 
blood group du testing
blood group du testing blood group du testing
blood group du testing rajesh kumar
 
Univ bacteriav PCR Primer
Univ bacteriav PCR PrimerUniv bacteriav PCR Primer
Univ bacteriav PCR PrimerZulkifli As
 
Recombinant Fab fragments specific for the pfHRPII and pfHSP72 : implications...
Recombinant Fab fragments specific for the pfHRPII and pfHSP72 : implications...Recombinant Fab fragments specific for the pfHRPII and pfHSP72 : implications...
Recombinant Fab fragments specific for the pfHRPII and pfHSP72 : implications...Institut Pasteur de Madagascar
 
KRIBIOLISA Drug Monitoring ELISA Atezolizumab
KRIBIOLISA Drug Monitoring ELISA AtezolizumabKRIBIOLISA Drug Monitoring ELISA Atezolizumab
KRIBIOLISA Drug Monitoring ELISA Atezolizumabkrishgen
 
ADCC Reporter Bioassay - V and F Variants: Novel, Bioluminescent Cell-Based A...
ADCC Reporter Bioassay - V and F Variants: Novel, Bioluminescent Cell-Based A...ADCC Reporter Bioassay - V and F Variants: Novel, Bioluminescent Cell-Based A...
ADCC Reporter Bioassay - V and F Variants: Novel, Bioluminescent Cell-Based A...Neal Cosby
 
Evaluation of Automated COBAS AMPLICOR PCR System for Detection of Several In...
Evaluation of Automated COBAS AMPLICOR PCR System for Detection of Several In...Evaluation of Automated COBAS AMPLICOR PCR System for Detection of Several In...
Evaluation of Automated COBAS AMPLICOR PCR System for Detection of Several In...Alberto Cuadrado
 
Immunohistochemistry analyses
Immunohistochemistry analysesImmunohistochemistry analyses
Immunohistochemistry analysesabizarl
 
ADCC Reporter Bioassay (AACR 2013)
ADCC Reporter Bioassay (AACR 2013)ADCC Reporter Bioassay (AACR 2013)
ADCC Reporter Bioassay (AACR 2013)Neal Cosby
 

Was ist angesagt? (20)

Lecture 3- agglutination test for
Lecture 3- agglutination test forLecture 3- agglutination test for
Lecture 3- agglutination test for
 
44-150724PST_Peptalk_2013_AlphaLISA_immunoassays
44-150724PST_Peptalk_2013_AlphaLISA_immunoassays44-150724PST_Peptalk_2013_AlphaLISA_immunoassays
44-150724PST_Peptalk_2013_AlphaLISA_immunoassays
 
ELISA and RIA
ELISA and RIAELISA and RIA
ELISA and RIA
 
Elisa
ElisaElisa
Elisa
 
Explaining Biocide Tolerance of Gram Negative Bacteria
Explaining Biocide Tolerance of Gram Negative Bacteria Explaining Biocide Tolerance of Gram Negative Bacteria
Explaining Biocide Tolerance of Gram Negative Bacteria
 
Sfnge array poster
Sfnge array posterSfnge array poster
Sfnge array poster
 
Radioimmunoassay and related immunoassay techniques
Radioimmunoassay and related immunoassay techniquesRadioimmunoassay and related immunoassay techniques
Radioimmunoassay and related immunoassay techniques
 
Radioimmunoassay
RadioimmunoassayRadioimmunoassay
Radioimmunoassay
 
Mammalian project poster
Mammalian project posterMammalian project poster
Mammalian project poster
 
Peritoneal Dialysis And Secondary Renal Function
Peritoneal Dialysis And Secondary Renal FunctionPeritoneal Dialysis And Secondary Renal Function
Peritoneal Dialysis And Secondary Renal Function
 
blood group du testing
blood group du testing blood group du testing
blood group du testing
 
Univ bacteriav PCR Primer
Univ bacteriav PCR PrimerUniv bacteriav PCR Primer
Univ bacteriav PCR Primer
 
Recombinant Fab fragments specific for the pfHRPII and pfHSP72 : implications...
Recombinant Fab fragments specific for the pfHRPII and pfHSP72 : implications...Recombinant Fab fragments specific for the pfHRPII and pfHSP72 : implications...
Recombinant Fab fragments specific for the pfHRPII and pfHSP72 : implications...
 
KRIBIOLISA Drug Monitoring ELISA Atezolizumab
KRIBIOLISA Drug Monitoring ELISA AtezolizumabKRIBIOLISA Drug Monitoring ELISA Atezolizumab
KRIBIOLISA Drug Monitoring ELISA Atezolizumab
 
ADCC Reporter Bioassay - V and F Variants: Novel, Bioluminescent Cell-Based A...
ADCC Reporter Bioassay - V and F Variants: Novel, Bioluminescent Cell-Based A...ADCC Reporter Bioassay - V and F Variants: Novel, Bioluminescent Cell-Based A...
ADCC Reporter Bioassay - V and F Variants: Novel, Bioluminescent Cell-Based A...
 
Evaluation of Automated COBAS AMPLICOR PCR System for Detection of Several In...
Evaluation of Automated COBAS AMPLICOR PCR System for Detection of Several In...Evaluation of Automated COBAS AMPLICOR PCR System for Detection of Several In...
Evaluation of Automated COBAS AMPLICOR PCR System for Detection of Several In...
 
Immunohistochemistry analyses
Immunohistochemistry analysesImmunohistochemistry analyses
Immunohistochemistry analyses
 
azad ria
azad riaazad ria
azad ria
 
ADCC Reporter Bioassay (AACR 2013)
ADCC Reporter Bioassay (AACR 2013)ADCC Reporter Bioassay (AACR 2013)
ADCC Reporter Bioassay (AACR 2013)
 
Coomb's test
Coomb's testCoomb's test
Coomb's test
 

Andere mochten auch

Tibaru15
Tibaru15Tibaru15
Tibaru15andreei
 
Pemeriksan laboratorium imunologi
Pemeriksan laboratorium imunologiPemeriksan laboratorium imunologi
Pemeriksan laboratorium imunologitristyanto
 
Kelompok 8 Kimia B ( Elektroforesis)
Kelompok 8 Kimia B ( Elektroforesis)Kelompok 8 Kimia B ( Elektroforesis)
Kelompok 8 Kimia B ( Elektroforesis)hasmachem
 
Biotech 2011-10-methods
Biotech 2011-10-methodsBiotech 2011-10-methods
Biotech 2011-10-methodsNikolay Vyahhi
 

Andere mochten auch (9)

Rkk26
Rkk26Rkk26
Rkk26
 
elektroforesis gel
elektroforesis gelelektroforesis gel
elektroforesis gel
 
Kimia klinik referat 2
Kimia klinik referat 2Kimia klinik referat 2
Kimia klinik referat 2
 
Ti9
Ti9Ti9
Ti9
 
Tibaru15
Tibaru15Tibaru15
Tibaru15
 
Pengantar imunoasai
Pengantar imunoasaiPengantar imunoasai
Pengantar imunoasai
 
Pemeriksan laboratorium imunologi
Pemeriksan laboratorium imunologiPemeriksan laboratorium imunologi
Pemeriksan laboratorium imunologi
 
Kelompok 8 Kimia B ( Elektroforesis)
Kelompok 8 Kimia B ( Elektroforesis)Kelompok 8 Kimia B ( Elektroforesis)
Kelompok 8 Kimia B ( Elektroforesis)
 
Biotech 2011-10-methods
Biotech 2011-10-methodsBiotech 2011-10-methods
Biotech 2011-10-methods
 

Ähnlich wie IgA Measurement Methods Comparison

Immunological Assays;RIA and ELISA.pjsjsptx
Immunological Assays;RIA and ELISA.pjsjsptxImmunological Assays;RIA and ELISA.pjsjsptx
Immunological Assays;RIA and ELISA.pjsjsptxanshikabhatnagar1299
 
Ria 112070804007
Ria 112070804007Ria 112070804007
Ria 112070804007Patel Parth
 
Imunbaru2
Imunbaru2Imunbaru2
Imunbaru2andreei
 
Usage of Immunological reactions in diagnostics of infectious diseases.
Usage of Immunological reactions in diagnostics of infectious diseases. Usage of Immunological reactions in diagnostics of infectious diseases.
Usage of Immunological reactions in diagnostics of infectious diseases. Eneutron
 
Biochemical assays.pptx
Biochemical assays.pptxBiochemical assays.pptx
Biochemical assays.pptxParimal Hadge
 
2_2023_01_10!03_2hehebsnwnwnan9_06_PM.ppt
2_2023_01_10!03_2hehebsnwnwnan9_06_PM.ppt2_2023_01_10!03_2hehebsnwnwnan9_06_PM.ppt
2_2023_01_10!03_2hehebsnwnwnan9_06_PM.pptLamaZein3
 
ria elisa biochem.pdf
ria elisa biochem.pdfria elisa biochem.pdf
ria elisa biochem.pdfRinaDas9
 
Double immunodiffusion technique
Double immunodiffusion techniqueDouble immunodiffusion technique
Double immunodiffusion techniquePrachee Rajput
 
67. ABO isoagglutinintitration application, method and controversies.pdf
67. ABO isoagglutinintitration application, method and controversies.pdf67. ABO isoagglutinintitration application, method and controversies.pdf
67. ABO isoagglutinintitration application, method and controversies.pdfDurbaBiswas7
 
Antigen antibody reaction (part: 2)
Antigen antibody reaction (part: 2)Antigen antibody reaction (part: 2)
Antigen antibody reaction (part: 2)Dr. Nimra Khan
 
ELISA_DrRashmi_Patel_CIMS_V02.pdf
ELISA_DrRashmi_Patel_CIMS_V02.pdfELISA_DrRashmi_Patel_CIMS_V02.pdf
ELISA_DrRashmi_Patel_CIMS_V02.pdfRashmiPatel190362
 
Immunoblotting-techniques-Class. Biotechnologypptx
Immunoblotting-techniques-Class. BiotechnologypptxImmunoblotting-techniques-Class. Biotechnologypptx
Immunoblotting-techniques-Class. Biotechnologypptxrakeshbarik8
 
principle instrumentation and application of capillary electrophoresis
principle instrumentation and application of capillary electrophoresisprinciple instrumentation and application of capillary electrophoresis
principle instrumentation and application of capillary electrophoresisAnimikh Ray
 
Immunoassay of digoxin
Immunoassay of digoxinImmunoassay of digoxin
Immunoassay of digoxinRashmi116
 
Serological tests with labelled antibody theoretical questions
Serological tests with labelled antibody theoretical questionsSerological tests with labelled antibody theoretical questions
Serological tests with labelled antibody theoretical questionsEneutron
 

Ähnlich wie IgA Measurement Methods Comparison (20)

Immunological Assays;RIA and ELISA.pjsjsptx
Immunological Assays;RIA and ELISA.pjsjsptxImmunological Assays;RIA and ELISA.pjsjsptx
Immunological Assays;RIA and ELISA.pjsjsptx
 
Ria 112070804007
Ria 112070804007Ria 112070804007
Ria 112070804007
 
Imunbaru2
Imunbaru2Imunbaru2
Imunbaru2
 
Usage of Immunological reactions in diagnostics of infectious diseases.
Usage of Immunological reactions in diagnostics of infectious diseases. Usage of Immunological reactions in diagnostics of infectious diseases.
Usage of Immunological reactions in diagnostics of infectious diseases.
 
Biochemical assays.pptx
Biochemical assays.pptxBiochemical assays.pptx
Biochemical assays.pptx
 
Elisa
ElisaElisa
Elisa
 
Khushbu_Simoa_06-16
Khushbu_Simoa_06-16Khushbu_Simoa_06-16
Khushbu_Simoa_06-16
 
2_2023_01_10!03_2hehebsnwnwnan9_06_PM.ppt
2_2023_01_10!03_2hehebsnwnwnan9_06_PM.ppt2_2023_01_10!03_2hehebsnwnwnan9_06_PM.ppt
2_2023_01_10!03_2hehebsnwnwnan9_06_PM.ppt
 
ria elisa biochem.pdf
ria elisa biochem.pdfria elisa biochem.pdf
ria elisa biochem.pdf
 
Double immunodiffusion technique
Double immunodiffusion techniqueDouble immunodiffusion technique
Double immunodiffusion technique
 
67. ABO isoagglutinintitration application, method and controversies.pdf
67. ABO isoagglutinintitration application, method and controversies.pdf67. ABO isoagglutinintitration application, method and controversies.pdf
67. ABO isoagglutinintitration application, method and controversies.pdf
 
Antigen antibody reaction (part: 2)
Antigen antibody reaction (part: 2)Antigen antibody reaction (part: 2)
Antigen antibody reaction (part: 2)
 
ELISA_DrRashmi_Patel_CIMS_V02.pdf
ELISA_DrRashmi_Patel_CIMS_V02.pdfELISA_DrRashmi_Patel_CIMS_V02.pdf
ELISA_DrRashmi_Patel_CIMS_V02.pdf
 
Immunoblotting-techniques-Class. Biotechnologypptx
Immunoblotting-techniques-Class. BiotechnologypptxImmunoblotting-techniques-Class. Biotechnologypptx
Immunoblotting-techniques-Class. Biotechnologypptx
 
Radioimmunoassay (ria)
Radioimmunoassay (ria)Radioimmunoassay (ria)
Radioimmunoassay (ria)
 
principle instrumentation and application of capillary electrophoresis
principle instrumentation and application of capillary electrophoresisprinciple instrumentation and application of capillary electrophoresis
principle instrumentation and application of capillary electrophoresis
 
Radioimmuno assay
Radioimmuno assay Radioimmuno assay
Radioimmuno assay
 
Immunoassay of digoxin
Immunoassay of digoxinImmunoassay of digoxin
Immunoassay of digoxin
 
Annals.1384.012
Annals.1384.012Annals.1384.012
Annals.1384.012
 
Serological tests with labelled antibody theoretical questions
Serological tests with labelled antibody theoretical questionsSerological tests with labelled antibody theoretical questions
Serological tests with labelled antibody theoretical questions
 

Mehr von andreei

Tibaru18
Tibaru18Tibaru18
Tibaru18andreei
 
Tibaru17
Tibaru17Tibaru17
Tibaru17andreei
 
Tibaru16
Tibaru16Tibaru16
Tibaru16andreei
 
Tibaru12
Tibaru12Tibaru12
Tibaru12andreei
 
Tibaru11
Tibaru11Tibaru11
Tibaru11andreei
 
Tibaru11
Tibaru11Tibaru11
Tibaru11andreei
 
Tibaru10
Tibaru10Tibaru10
Tibaru10andreei
 
Refhemabaru8
Refhemabaru8Refhemabaru8
Refhemabaru8andreei
 
Refhemabaru7
Refhemabaru7Refhemabaru7
Refhemabaru7andreei
 
Refhemabaru6
Refhemabaru6Refhemabaru6
Refhemabaru6andreei
 
Refhemabaru5
Refhemabaru5Refhemabaru5
Refhemabaru5andreei
 
Tutor hematologi
Tutor hematologiTutor hematologi
Tutor hematologiandreei
 
Tutor hema sutul
Tutor hema sutulTutor hema sutul
Tutor hema sutulandreei
 

Mehr von andreei (20)

Tibaru18
Tibaru18Tibaru18
Tibaru18
 
Tibaru17
Tibaru17Tibaru17
Tibaru17
 
Tibaru16
Tibaru16Tibaru16
Tibaru16
 
Tibaru12
Tibaru12Tibaru12
Tibaru12
 
Tibaru11
Tibaru11Tibaru11
Tibaru11
 
Tibaru9
Tibaru9Tibaru9
Tibaru9
 
Tibaru11
Tibaru11Tibaru11
Tibaru11
 
Tibaru10
Tibaru10Tibaru10
Tibaru10
 
Tibaru8
Tibaru8Tibaru8
Tibaru8
 
Tibaru7
Tibaru7Tibaru7
Tibaru7
 
Refhemabaru8
Refhemabaru8Refhemabaru8
Refhemabaru8
 
Refhemabaru7
Refhemabaru7Refhemabaru7
Refhemabaru7
 
Refhemabaru6
Refhemabaru6Refhemabaru6
Refhemabaru6
 
Refhemabaru5
Refhemabaru5Refhemabaru5
Refhemabaru5
 
12
1212
12
 
12
1212
12
 
11
1111
11
 
Tutor hematologi
Tutor hematologiTutor hematologi
Tutor hematologi
 
10
1010
10
 
Tutor hema sutul
Tutor hema sutulTutor hema sutul
Tutor hema sutul
 

Kürzlich hochgeladen

Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamAkebom Gebremichael
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingSakthi Kathiravan
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSapna Thakur
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...Divya Kanojiya
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 

Kürzlich hochgeladen (20)

Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursing
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna ThakurSCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
SCHOOL HEALTH SERVICES.pptx made by Sapna Thakur
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 

IgA Measurement Methods Comparison

  • 1. Pemeriksaan Immunoglobulin A (IgA) dengan metode Radial Immunodiffusion Ferdy,dr/ Endang Retnowati, dr, MS, SpPK(K) TUTOR IMUNOLOGI 1
  • 2. 2 subklas: IgA1 dan IgA2 Antibodi penting pada imunitas mukosa. IgA 3-5 gram/hari disekresi ke lumen intestinal 75% Ig total dihasilkan tubuh 2 Pendahuluan
  • 3. Struktur Ig A Gambar 1: Struktur Ig A (Sumber: Siemel, 2006) 3
  • 5. Arti klinis Ig A menurun: Selective IgA deficiency Infeksi Neisseria gonorrhœae 5
  • 6. IgA meningkat Ig A nephropathy Penyakit kronis seperti hepatitis Sirosis hepatis Myeloma Penyakit autoimun seperti SLE 6
  • 7. Pemeriksaan Immunoglobulin A Metode : Radial immunodifusion Radioimmunoassay Nefelometri ELISA 7
  • 9. 9
  • 10. Kurva Presipitasi Gambar2. KurvaPresipitasi. (Sheehan, 1990) 10
  • 11. Gambar3. Kompleks Ag – Ab. (Sheehan, 1990) 11
  • 12. RADIAL IMMUNODIFFUSION (RID) 12 Antisera/ Ab Gel agarosa fase cair (50oC) 50 – 80 jam  cincin presipitasi Serum standar 1 Tes serum 2 8 Antisera dalam agar Tes serum 3 dinginkan pd suhu kamar 7 Tes serum 4 Ukur diameter cincin presipitasi, tempatkan pd kurva standar  menentukan kadar imunoglobulin secara kuantitatif 6 5 Tes serum Tes serum (Handojo, 2003)
  • 13. KECEPATAN DIFUSI Ukuran molekul Interaksi matriks gel & reaktan FAKTOR Viskositas & Hidrasi gel Berat molekul Ag Temperatur 13 (Sheehan, 1990)
  • 14. CARA PEMBACAAN RID METODE Mancini, endpoint diffusion. Fahey, kinetic diffusion. 14 (Sheehan, 1990)
  • 15.
  • 17. sumbu x :diameter cincinpresipitasi (termasuksumuran)
  • 20. Grafik; sumbu y:kadar Ag & sumbux: cincinpresipitasi. 15 (Sheehan, 1990)
  • 21. Gambar 4. Grafik Fahey (kinetic diffusion method) 16 (Sheehan, 1990)
  • 22. Gambar 5. Grafik Mancini (endpoint method) 17 (Sheehan, 1990)
  • 23. 18 HASIL Hasil dikali faktor pengenceran Hasil kurang dari standar (Sheehan, 1990)
  • 24. mengisi sumuran terlalu sedikit/ banyak menumpahkan serum pasien ke dalam gel agarosa hasiltdkakurat perludiulang melubangi samping sumuran Waktu&suhu Inkubasi tdk tepat KESALAHAN PEMBACAAN RID (Sheehan, 1990) 19
  • 26. Pemeriksaan IgA di Instalasi Patologi Klinik RSUD.dr.Soetomo Prinsip pemeriksaan (RID): Ig A serum/plasma manusia membentuk kompleks imun dengan antibodi spesifik pada gel agarose pada cakram Partigen Diameter cincin presipitasi berbanding lurus dengan konsentrasi Ig A dalam sampel Hasil dikonversi ke dalam konsentrasi Ig A menggunakan tabel nilai referensi. 21
  • 27. Reagen: Tiap plate NOR partigen mempunyai 12 sumuran imunodifusi untuk menentukan Ig A serum/plasma. Komposisi: Cakram NOR partigen mengandung lapisan agarose gel yang mengandung antiserum monospesifik terhadap Ig A dalam plasma. Antisera diperoleh dari kelinci, domba, kuda, kambing yang diimunisasi dari manusia. Cakram NOR Partigen juga mengandung sodium azide (<1 g/l) dan sodium timerfonate (<0.1 g/l) sebagai pengawet. 22
  • 28. 23 Gambar7. NOR Partigen Plate (Lab. PK, 2011)
  • 29. Penyimpanan dan stabilitas NOR Patigen sebaiknya disimpan pada suhu 2-8°C pada pembungkus yang belum dibuka, stabil sesuai masa berlaku Kontrol Sebaiknya digunakan kontrol sampel yang tersedia komersial 24
  • 30. Spesimen serum maupun plasma segar (24 jam sesudah pengambilan) bila sampel tidak langsung dikerjakan sebaiknya disimpan pada suhu 2-8°C maksimum 8 hari Penyimpanan pada suhu -20°C dapat bertahan hingga 1 tahun. 25
  • 31. Prosedur 5 µl sampel 1 Tes serum 2 8 Antisera dalam agar Tes serum 3 7 UKUR DIAMETER CINCIN PRESIPITASI SETELAH 48 JAM Tes serum 4 6 5 Tes serum Tes serum (Handojo, 2003) 26
  • 32. Gambar8. Meβ Projector, Lab. PK. Dr. Soetomo, 2011 27
  • 33. 28 Gambar9. TabelReferensi (Lab. PK, 2010)
  • 34. Nilai normal IgA : 70 – 350 mg/ dL 29
  • 36. we defined IgA deficiency as plasma samples with less than 100 ngIgA per mL, decreased level of IgA as plasma samples with 100 ng to600 mg IgA per mL, and normal level of IgA as plasmasamples with more than 0.6 mg per mL as determined by the IgA-ELISA 31
  • 37. IgA measurement by nephelometry Beckman Coulter, Inc. (Fullerton,Calif.). IgA levels were considered deficient when they were less than thelower limit of established age-dependent reference intervals. These limits: 70 mg/dl for teenagers and adults, 23 mg/dl for children 3 to 12 years old, 17mg/dl for children ,3 years old. 32
  • 39. 34 NEFELOMETRI Nephelometri : carapengukurankadarzatdenganmengukurpendarancahaya (scattered) yang mengenaipartikeldalamlarutan. Dasarpemeriksaan : reaksipresipitasi antigen-antibodi. Metodeinidigunakanuntukmengetahuikuantitas protein spesifiksecaralebihakuratdanprecise.
  • 40. 35 PRINSIP NEPHELOMETRI (1) Prinsip nephelometri : 1. pendaran cahaya, 2. kinetik cairan pada fase presipitasi.
  • 41. 36 PRINSIP NEPHELOMETRI (2) PENDARAN CAHAYA Pendarancahayadipengaruhi : a. diameter partikel, b. panjanggelombang. Contoh : a. partikelkecil (albumin, Ig.G,Ig.M) : - pendarancahaya Rayleigh semetrisantaraforwarddanbackward. - pendarancahaya minimum dilihatpada90º darisumbercahaya.
  • 42. 37 PRINSIP NEPHELOMETRI (3) b. partikellebihbesar (komplek Ag-Ab) : - menghasilkanpendarancahayaRaeyleigh-Debye - pendarandilihatdariforward (sudutmendekatinol) intensitascahayalebihbesar. Sudutuntukmendeteksipendarancahayaikutmenentukansensitivitas, dimanaintensitassumbercahayamakinkuatmakasudut yang dihasilkanmakinkecil
  • 45. 40 PRINSIP NEPHELOMETRI (6) 2. KINETIK CAIRAN PADA FASE PRESIPITASI Sinartampak (visible) yang mengenaibentukanlatticependarancahaya Rayleigh-Debye. Latticemaksimalzonaekivalen. Nephelometrimengukurkonsentrasi antigen padakeadaankelebihanantibodi, dimanaterdapatjumlahlattice pendarancahaya yang terukursesuaijumlah antigen sampel.
  • 46. Low values Ig A Some people are born with low or absent levels of IgA antibodies. Low levels of IgA occur in some types of leukemia, kidney damage (nephrotic syndrome) a problem with the intestines (enteropathy) a rare inherited disease that affects muscle coordination (ataxia-telangiectasia). 41
  • 47. High values IgA monoclonal gammopathy of unknown significance (MGUS) or multiple myeloma autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus (SLE), and in liver diseases, such as cirrhosis and long-term (chronic) hepatitis. 42
  • 48. 3 most commonly used methods for the quantitative determination of serum IgA concentration: nephelometry (or turbidimetry), passive hemagglutination inhibition assay (PHAI), and enzyme-linked immunosorbent assay (ELISA). The basic principle of nephelometric and turbidimetric assays for quantifying IgA concentration is light scatter at various angles by immune complexes formed between IgA (antigen) in the patient's serum and anti-IgA (antibody) antiserum added to the patient's serum. Passive hemagglutination techniques use hemagglutination as the end point of the antigen-antibody reaction, while ELISA methods use a capture antibody bound to the well of a microtiter plate to "capture" antigen (eg, IgA) and a signal antibody, containing an enzyme "signal", that recognizes a different epitope on the antigen than the capture antibody. The addition of substrate specific for the enzyme attached to the signal antibody results in the production of a color whose intensity is directly proportional to the amount of antigen present. 43
  • 49. Among these methods for the quantitation of IgA concentration, ELISA methods provide the best analytical sensitivity [ie, lower limit of detection (LLD) <0.005 mg/dL] ( Table 2 ). Nephelometric or turbidimetric methods are used routinely in most clinical laboratories for the quantitation of serum IgA concentration because these methods are rapid, easy to use, and are amenable to automation. According to the data in the College of American Pathologists (CAP) 2004 Diagnostic Immunology Survey Set-B Summary, 93.6% (712 of 760) of participating laboratories used nephelometric or turbidimetric methods for the quantitation of IgA, with the majority (55.2%) of these laboratories reporting the use of nephelometry over turbidimetry.[2] 44